Clinical trials
Observational Ischemic Attack, Transient trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunnybrook Health Sciences Centre | 4 |
| University of Alberta | 3 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Dr. Richard H. Swartz | 1 |
| Dr. Sandra E Black | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Toronto Rehabilitation Institute | 1 |
| University of Illinois at Chicago | 1 |
| University of Maryland, Baltimore | 1 |
| Vancouver Coastal Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Attack, Transient | 16 |
| Stroke | 9 |
| Ischemic Stroke | 4 |
| Cognitive Dysfunction | 3 |
| Atrial Fibrillation | 2 |
| Carotid Stenosis | 2 |
| Sleep Apnea, Obstructive | 2 |
| Acute Coronary Syndrome | 1 |
| Alzheimer Disease | 1 |
| Anemia | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.